Treatment outcome and clinical characteristics of HER2 mutated advanced non‐small cell lung cancer patients in China

BACKGROUND: HER2 mutation is found in 1%–2% of lung cancer patients. Studies comparing chemotherapy to HER2‐TKIs are limited. This study aimed to investigate the molecular and clinical patterns of HER2 mutations in advanced non‐small cell lung cancer (NSCLC), and compare the different outcomes betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Yang, Guangjian, Xu, Haiyan, Yang, Lu, Qiu, Weini, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049517/
https://www.ncbi.nlm.nih.gov/pubmed/31975535
http://dx.doi.org/10.1111/1759-7714.13317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049517/
https://www.ncbi.nlm.nih.gov/pubmed/31975535
http://dx.doi.org/10.1111/1759-7714.13317

Ejemplares similares